Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]

P. Rosenstiel, J. Agnholt, J. Kelsen, Valentina Medici, G. H. Waetzig, D. Seegert, S. Schreiber, A. Di Sabatino, R. Ciccocioppo, R. Morera, G. R. Corazza

Research output: Contribution to journalArticle

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)314-316
Number of pages3
JournalGut
Volume54
Issue number2
StatePublished - Feb 2005
Externally publishedYes

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Rosenstiel, P., Agnholt, J., Kelsen, J., Medici, V., Waetzig, G. H., Seegert, D., Schreiber, S., Di Sabatino, A., Ciccocioppo, R., Morera, R., & Corazza, G. R. (2005). Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]. Gut, 54(2), 314-316.